EGFR and cancer: To enhance the intracellular uptake and eliminate the non-specific binding of anticancer drugs into cancer cells, ND that carried PTX combined with cetuximab (Cet), a specific monoclonal antibody against epidermal growth factor receptor (EGFR), was designed.